Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 99.56x is 164% above its 1-year average of 37.76x, near the high end of its 1-year range (-24.04x–99.56x).
As of the fiscal period ended Thursday, December 31, 2020. 163.66% above its 12-month average of 37.76x.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
99.56x
INTEREST COVERAGE RATIO AVG TTM
37.76x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+163.66%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 362 covered companies
CURRENT VS SECTOR MEDIAN
+2453.65%
vs the sector median at left
AbCellera Biologics Inc.
Market Cap
$4.16B
Interest Coverage Ratio
99.56x
TTM Avg
37.76x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.16B
Interest Coverage Ratio
4.05x
TTM Avg
3.05x
3Y Avg
3.05x
5Y Avg
3.05x
Market Cap
$4.30B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.33B
Interest Coverage Ratio
-4.22x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.97B
Interest Coverage Ratio
1.01x
TTM Avg
0.71x
3Y Avg
0.54x
5Y Avg
40.25x
Market Cap
$4.41B
Interest Coverage Ratio
5.89x
TTM Avg
3.33x
3Y Avg
3.33x
5Y Avg
4.95x
Market Cap
$4.56B
Interest Coverage Ratio
-4.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.67B
Interest Coverage Ratio
-30.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.68B
Interest Coverage Ratio
2.07x
TTM Avg
2.07x
3Y Avg
2.07x
5Y Avg
1.38x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $4.16B | 99.56x | 37.76x | N/A | N/A |
| LivaNova PLC (LIVN)vs › | $4.16B | 4.05x | 3.05x | 3.05x | 3.05x |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.30B | N/A | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.33B | -4.22x | N/A | N/A | N/A |
| ICU Medical, Inc. (ICUI)vs › | $3.97B | 1.01x | 0.71x | 0.54x | 40.25x |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.41B | 5.89x | 3.33x | 3.33x | 4.95x |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.56B | -4.85x | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.67B | -30.34x | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 2.07x | 2.07x | 2.07x | 1.38x |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.72B | N/A | N/A | N/A | N/A |
Interest Coverage
99.6x
Debt/Equity
0.15
Current Ratio
12.77
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2020-12-31 | 99.56x |
| 2019-12-31 | -24.04x |
